Creating Biomedical Technologies to Improve Health

FAQs for NIBIB Supplements to NCATS CTSA Programs for Translational Research Teams of Quantitative Researchers and Clinician-Scientists (Admin Supp)

Program Announcement: PA-18-426

  1. Which CTSAs are eligible to apply?

    An eligible CTSA Program hub will have at least 2 years remaining on the award at the time of the supplement award.  CTSA Program hubs that have a pending renewal application for FY 2019 are also eligible as discussed in Question 10 below.

  2. What are the qualifications for the NIBIB Translational Research Scholar and the partnering clinician scientist?

    The quantitative research must hold a doctoral degree (or equivalent degree) in the computational or physical sciences, currently hold the position of tenure track or research track assistant professor or similar faculty position. The clinician-scientist must hold an M.D. or M.D./Ph.D.  (or an equivalent degree) and have a demonstrated interest in conducting translational research. Both team members must have faculty appointments from the same actively awarded CTSA or partnering institution.

  3. Will the partnering clinician-scientist be supported by the FOA?

    No, the clinician-scientist will be supported by the KL2 award.  He/she is expected to be appointed to an actively funded KL2 program at the time of application or a plan should be included in the institutional letter of commitment to appoint them to the program if the supplement is funded.

  4. What costs are covered under this supplement?

    The NIBIB will contribute up to $170,000 in direct costs associated with the NIBIB Translational Research Scholar. This will include to $120,000 salary for minimum of 75% effort (9 person-months) and $50,000 for other direct costs including tuition and fees, research expenses, statistical services, and up to $2,500 for travel to research meetings and workshops.

  5. Does the NIBIB Translational Research Scholar need to be appointed to the NCATS KL2 program?

    The NIBIB Translational Research Scholar cannot be appointed to an existing KL2 program at the time of the application but will be appointed if the supplement is funded.

  6. Can either team member have other NIH grants?

    Candidates who have had or currently hold R01s, P01, P50s, K awards, NIBIB R21 trailblazers, and their sub-projects or equivalent grants are not eligible. Current and former PD/PIs of R03s, R21s, R36s, or any SBIR/STTR remain eligible.  Both the NIBIB Translational Research Scholar and the partnering clinician scientist must meet this criterion.

  7. Are mentors required for this supplement?

    Yes, at least one basic science and one clinical mentor are required for the research team.

  8. Do proposed projects require the involvement of both the NIBIB Translational Research Scholar and the clinician-scientist?

    Yes, both partners must make significant contributions to both the planning and execution of the proposed research project.

  9. What letters of support are required for the application?

    Applications must include a letter of support from the institution that outlines their acceptance and support for the proposed research project and the partnering clinician-scientist's and the NIBIB Translational Research Scholar's appointment to the KL2 program. Applications must also include letters of support from the KL2 program director(s), the research team mentor(s), collaborator(s), and any relevant department chairs and facility director(s).

  10. Are Institutions that have submitted renewal applications eligible to apply?

    Yes, CTSA hubs that have submitted a renewal application and have a pending application for FY 2019.  However, the supplement will only be considered if the renewal application is funded.

  11. Can an appointee be from a different institution?

    Both research team partners must have faculty appointments at the CTSA institution (including partner institutions.)

  12. What types of projects are appropriate for this supplement?

    The proposed research should strictly address one or more of the Scientific Program Areas supported by the NIBIB. Applicants are strongly encouraged to contact Dr. Zeynep Erim with the proposed specific aims and team member CVs to determine eligibility before starting to work on the application.

  13. Is the PI responsible for finding and matching the team members or does NIBIB do this?

    The PD/PI of the active CTSA KL2 program will recruit and nominate scholars for this supplement. Both team members will be approved by the KL2 PD/PI. The NIBIB Translational Research Scholar candidate must not already be appointed to the KL2 at the time of the application, but will be appointed to the KL2 program, if the supplement is awarded.

For further information contact:

Zeynep Erim
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Telephone: (301) 451-4797
Email: erimz@mail.nih.gov